Neurometrix Company Profile (NASDAQ:NURO)

About Neurometrix (NASDAQ:NURO)

Neurometrix logoNeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NURO
  • CUSIP: N/A
  • Web:
  • Market Cap: $4.37 million
  • Outstanding Shares: 1,268,000
Average Prices:
  • 50 Day Moving Avg: $1.59
  • 200 Day Moving Avg: $0.99
  • 52 Week Range: $0.38 - $4.50
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.26
  • P/E Growth: -0.02
Sales & Book Value:
  • Annual Revenue: $14.06 million
  • Price / Sales: 0.31
  • Book Value: $7.19 per share
  • Price / Book: 0.48
  • EBIDTA: ($14,270,000.00)
  • Net Margins: -124.01%
  • Return on Equity: -181.47%
  • Return on Assets: -129.09%
  • Current Ratio: 2.29%
  • Quick Ratio: 1.91%
  • Average Volume: 180,925 shs.
  • Beta: 0.1
  • Short Ratio: 3.66

Frequently Asked Questions for Neurometrix (NASDAQ:NURO)

What is Neurometrix's stock symbol?

Neurometrix trades on the NASDAQ under the ticker symbol "NURO."

When did Neurometrix's stock split? How did Neurometrix's stock split work?

Shares of Neurometrix reverse split before market open on Friday, May 12th 2017. The 1-8 reverse split was announced on Thursday, May 11th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, May 11th 2017. An investor that had 100 shares of Neurometrix stock prior to the reverse split would have 13 shares after the split.

How were Neurometrix's earnings last quarter?

Neurometrix Inc (NASDAQ:NURO) released its earnings results on Thursday, April, 20th. The company reported ($7.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($3.92) by $3.36. The business earned $4.31 million during the quarter, compared to analysts' expectations of $4.17 million. Neurometrix had a negative net margin of 124.01% and a negative return on equity of 181.47%. View Neurometrix's Earnings History.

Where is Neurometrix's stock going? Where will Neurometrix's stock price be in 2017?

2 equities research analysts have issued 12-month target prices for Neurometrix's shares. Their predictions range from $36.00 to $36.00. On average, they expect Neurometrix's stock price to reach $36.00 in the next year. View Analyst Ratings for Neurometrix.

Who are some of Neurometrix's key competitors?

Who owns Neurometrix stock?

Neurometrix's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Sabby Management LLC (2.98%). Company insiders that own Neurometrix stock include Francis X Mcgillin, Shai Gozani and Thomas T Higgins. View Institutional Ownership Trends for Neurometrix.

Who bought Neurometrix stock? Who is buying Neurometrix stock?

Neurometrix's stock was purchased by a variety of institutional investors in the last quarter, including Sabby Management LLC. Company insiders that have bought Neurometrix stock in the last two years include Francis X Mcgillin, Shai Gozani and Thomas T Higgins. View Insider Buying and Selling for Neurometrix.

How do I buy Neurometrix stock?

Shares of Neurometrix can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Neurometrix stock cost?

One share of Neurometrix stock can currently be purchased for approximately $3.45.

Analyst Ratings

Consensus Ratings for Neurometrix (NASDAQ:NURO) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $36.00 (943.48% upside)

Analysts' Ratings History for Neurometrix (NASDAQ:NURO)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/23/2016HC WainwrightReiterated RatingBuy$36.00N/AView Rating Details
10/21/2016Rodman & RenshawReiterated RatingBuy$36.00N/AView Rating Details
2/29/2016Dawson JamesReiterated RatingBuyN/AView Rating Details
9/11/2015Maxim GroupInitiated CoverageBuy$64.00N/AView Rating Details
(Data available from 5/28/2015 forward)


Earnings History for Neurometrix (NASDAQ:NURO)
Earnings by Quarter for Neurometrix (NASDAQ:NURO)
Earnings History by Quarter for Neurometrix (NASDAQ:NURO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/20/2017Q1 2017($3.92)($7.28)$4.17 million$4.31 millionViewN/AView Earnings Details
1/26/2017Q416($6.00)($4.16)$3.48 million$3.70 millionViewListenView Earnings Details
10/20/2016Q316($6.56)($6.08)$3.01 million$3.39 millionViewListenView Earnings Details
7/21/2016Q216($7.44)($42.96)$1.22 million$2.65 millionViewListenView Earnings Details
4/21/2016Q116($7.60)($8.00)$2.65 million$2.28 millionViewListenView Earnings Details
10/22/2015Q315($0.64)($2.08)$6.47 million$2.10 millionViewListenView Earnings Details
7/22/2015Q215($3.84)$9.80 million$1.22 millionViewListenView Earnings Details
2/12/2015Q414($2.88)$4.62 million$1.41 millionViewN/AView Earnings Details
7/24/2014Q413($6.80)$1.16 million$1.34 millionViewN/AView Earnings Details
2/13/2014($6.96)ViewListenView Earnings Details
10/23/2013Q313($2.08)$1.77 million$1.31 millionViewListenView Earnings Details
7/25/2013Q2 2013($7.36)$2.20 million$1.20 millionViewN/AView Earnings Details
2/3/2011($1.36)($1.44)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Neurometrix (NASDAQ:NURO)
Current Year EPS Consensus Estimate: $-10.50 EPS
Next Year EPS Consensus Estimate: $-2.73 EPS


Dividend History for Neurometrix (NASDAQ:NURO)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Neurometrix (NASDAQ:NURO)
Insider Ownership Percentage: 5.90%
Institutional Ownership Percentage: 6.14%
Insider Trades by Quarter for Neurometrix (NASDAQ:NURO)
Institutional Ownership by Quarter for Neurometrix (NASDAQ:NURO)
Insider Trades by Quarter for Neurometrix (NASDAQ:NURO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/1/2016Shai GozaniCEOBuy3,000$1.31$3,930.00View SEC Filing  
10/28/2016Thomas T HigginsInsiderBuy3,000$1.32$3,960.00View SEC Filing  
10/27/2016Shai GozaniCEOBuy6,000$1.32$7,920.00View SEC Filing  
8/31/2016Thomas T HigginsCFOBuy1,400$1.41$1,974.00View SEC Filing  
8/18/2016Shai GozaniCEOBuy5,000$1.49$7,450.00View SEC Filing  
8/12/2016Thomas T HigginsInsiderBuy2,000$1.45$2,900.00View SEC Filing  
6/1/2016Shai GozaniCEOBuy2,500$1.71$4,275.00View SEC Filing  
5/23/2016Francis X McgillinVPBuy1,000$1.65$1,650.00View SEC Filing  
5/19/2016Shai GozaniCEOBuy12,000$1.55$18,600.00View SEC Filing  
5/19/2016Thomas T HigginsCFOBuy3,200$1.54$4,928.00View SEC Filing  
8/28/2015Thomas T HigginsCFOBuy4,500$0.92$4,140.00View SEC Filing  
8/20/2015Thomas T HigginsCFOBuy5,500$0.91$5,005.00View SEC Filing  
8/11/2015Shai GozaniCEOBuy16,300$0.91$14,833.00View SEC Filing  
11/9/2012Shai GozaniCEOBuy26,800$0.55$14,740.00View SEC Filing  
8/27/2012Krishnamurthy BalachandranCOOBuy5,000$0.67$3,350.00View SEC Filing  
8/21/2012Thomas T HigginsCFOBuy5,000$0.64$3,200.00View SEC Filing  
8/13/2012Krishnamurthy BalachandranCOOBuy5,000$0.70$3,500.00View SEC Filing  
8/8/2012Thomas T HigginsCFOBuy5,000$0.70$3,500.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Neurometrix (NASDAQ:NURO)
Latest Headlines for Neurometrix (NASDAQ:NURO)
DateHeadline logoNeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology - May 22 at 6:10 PM logoNeurometrix Inc (NURO) Upgraded to Hold at Zacks Investment Research - May 18 at 2:50 PM logoNeuroMetrix Wins SBANE New England Innovation Award - May 17 at 6:52 PM logoNeuroMetrix (NURO) Says Preliminary Results from Study Evaluating Quell in Chemotherapy-Induced Peripheral Neuropathy to be Presented at APS Meeting - May 16 at 10:10 AM logoNeuroMetrix Launches the LivingQuell Blog, a New Platform for Exploring Perspectives on Chronic Pain - May 16 at 10:10 AM logoPreliminary Results from Clinical Study Evaluating Use of Quell in Chemotherapy-Induced Peripheral Neuropathy to be presented at the American Pain Society Annual Meeting - May 15 at 6:14 PM logoNeuroMetrix (NURO) Declares 1-for-8 Reverse Stock Split - May 13 at 8:20 AM logoNeuroMetrix Announces One-for-Eight Reverse Split - May 11 at 7:24 PM logoNeuroMetrix (NURO) Announces Expansion of International Intellectual Property Assets for Quell - May 8 at 6:24 PM logoNeuroMetrix Reports Substantial Expansion of International Intellectual Property Assets for Quell Wearable Pain Relief Technology - May 8 at 12:15 PM logoNeuroMetrix Hosts Inaugural Quell User Event - May 5 at 7:11 PM logoNeurometrix (NURO) Getting Somewhat Positive Media Coverage, Analysis Finds - May 3 at 3:24 PM logoNeurometrix (NURO) Earns Daily News Sentiment Score of 0.04 - April 29 at 11:59 AM logoNeurometrix (NURO) Earning Somewhat Favorable Press Coverage, Analysis Finds - April 26 at 12:28 PM logoNeurometrix Inc (NURO) Short Interest Update - April 25 at 8:24 PM logoNeurometrix (NURO) Earns Daily Media Sentiment Score of 0.22 - April 21 at 8:08 PM logoNeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q1, 2017 By the Numbers : April 21, 2017 - April 21 at 6:49 PM logoNeurometrix Inc (NURO) Releases Earnings Results - April 21 at 1:17 PM logoEdited Transcript of NURO earnings conference call or presentation 20-Apr-17 12:00pm GMT - April 21 at 12:00 AM logoNeuroMetrix Reports Q1 2017 Financial Results - April 20 at 9:22 AM logoNeuroMetrix Review Ahead of Thursday's Earnings Call - April 19 at 10:11 AM logoNeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Bed Bath & Beyond - April 18 at 6:16 PM logoSomewhat Positive News Coverage Extremely Likely to Impact Neurometrix (NURO) Share Price - April 18 at 2:52 PM logoNeurometrix Inc (NURO) to Release Quarterly Earnings on Wednesday - April 17 at 9:22 AM logoNeuroMetrix Named a 50+ Innovation Leader - April 13 at 6:42 PM logoFavorable Press Coverage Extremely Likely to Effect Neurometrix (NURO) Stock Price - April 13 at 12:24 PM logoNeuroMetrix, Inc. Announces Date for 2017 First Quarter Financial Results Conference Call - Business Wire (press release) - April 12 at 7:51 PM logoNeuroMetrix, Inc. Announces Date for 2017 First Quarter Financial Results Conference Call - April 12 at 7:51 PM logoNeurometrix Inc (NURO) Lowered to Hold at Zacks Investment Research - March 30 at 9:04 AM logoNeuroMetrix Brings Quell Wearable for Pain Relief to American Academy of Pain Medicine 33rd Annual Meeting - March 15 at 7:06 PM logoNeurometrix Inc (NURO) Upgraded to “Buy” by Zacks Investment Research - March 9 at 1:28 AM logoNeuroMetrix Gaining Increased Media Coverage of Quell Wearable Pain Relief Technology in 2017 - March 1 at 7:04 PM logoNEUROMETRIX, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders - February 28 at 6:59 PM logoNeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Best Buy - February 21 at 5:57 PM logoNEUROMETRIX, INC. Financials - February 16 at 6:30 PM logoNEUROMETRIX, INC. Financials - February 16 at 6:30 PM logoNEUROMETRIX, INC. Files SEC form 10-K, Annual Report - February 9 at 7:59 PM logoNEUROMETRIX, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; - February 8 at 7:51 PM logoNeuroMetrix Reports Q4 and Full Year 2016 Financial Results - January 26 at 11:44 PM logoQ4 2016 NeuroMetrix Inc Earnings Release - Before Market Open - January 26 at 11:44 PM logoNEUROMETRIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit - January 26 at 11:43 PM logo7:20 am NeuroMetrix reports Q4 results; rev +36% y/y to $3.7 mln - January 26 at 11:43 PM logoNeuroMetrix Inc Earnings Call scheduled for 8:00 am ET today - January 26 at 11:43 PM logoNeuroMetrix, Inc. Announces Date for 2016 Full Year and Fourth Quarter Financial Results Conference Call - January 20 at 7:44 PM logo7:01 am NeuroMetrix reports Q4 demand for its Quell Technology, invoiced value of shipments totaled approximately $3.5 mln (+19% Q/Q) - January 10 at 7:49 PM logoNeuroMetrix says Quell up 19% sequentially in Q4 - Seeking Alpha - January 10 at 8:54 AM logoNeuroMetrix Reports Strong Quell Demand in Q4 2016 - January 10 at 8:54 AM logoCES 2017: NeuroMetrix Brings Life-Enhancing Technology to Those Suffering from Chronic Pain - January 3 at 10:13 PM logoNeuroMetrix to Present at Biotech Showcase 2017 - Business Wire (press release) - January 3 at 5:11 PM logoNeuroMetrix (NURO) Enters $7M Private Placement of Preferred ... - - December 28 at 11:49 PM



Neurometrix (NURO) Chart for Sunday, May, 28, 2017

This page was last updated on 5/28/2017 by Staff